095700 — Genexine Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩288bn
- KR₩304bn
- KR₩4bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -16,509 | 27,536 | -48,561 | -57,132 | -66,860 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -22,413 | -62,256 | 33,990 | 30,851 | 17,808 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5,153 | 9,109 | -1,473 | -18,328 | 6,029 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -41,572 | -22,691 | -12,745 | -39,800 | -38,055 |
Capital Expenditures | -5,082 | -24,116 | -57,007 | -31,779 | -7,379 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 6,719 | -40,278 | 49,302 | 29,864 | -26,904 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 1,637 | -64,394 | -7,704 | -1,915 | -34,283 |
Financing Cash Flow Items | — | — | 6,471 | — | -13,117 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3,328 | 73,358 | 43,087 | 31,632 | 60,427 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -36,627 | -13,881 | 22,584 | -9,853 | -11,910 |